Posts Tagged ‘Rheumatoid Arthritis Drug’
Could drinking help thwart rheumatoid arthritis?
July 28th, 2010 | 
Author: 
Could drinking help thwart rheumatoid arthritis?
Drinking alcohol may help keep rheumatoid arthritis at bay, possibly because it dampens the body’s immune response, new research suggests.
Read more on KIVI Boise
In the Rheumatoid Arthritis Drug Market, the Uptake of Alternative Biologics Such as Roche/Chugai’s Actemra/RoActemra …
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the rheumatoid arthritis drug market, the uptake of alternative biologics such as Roche/Chugai’s Actemra/RoActemra will erode the market share of TNF-alpha inhibitors over the next decade.
Read more on PR Newswire via Yahoo! Finance
Alcohol consumption reduces risk of rheumatoid arthritis: Study
Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research published today. It is the first time that this effect has been shown in humans. The study also finds that alcohol consumption reduces the risk of developing the disease, confirming the results of previous studies.
Read more on News-Medical-Net
Posted in Rheumatoid Arthritis | 
Tags: Actemra, Advisory Firms, Alcohol Consumption, Arthritis, Arthritis Rheumatoid, biologics, Chugai, could, Decision Resources, Drinking, Drinking Alcohol, Healthcare Issues, Help, Immune Response, Kivi Boise, Leading Research, Market Share, Pr Newswire, Rheumatoid, Rheumatoid Arthritis, Rheumatoid Arthritis Drug, Roche, Severity, thwart, Tnf Alpha | 
No Comments »
FDA Adds Information on Severe Liver Injury to Leflunomide’s Boxed Warning
FDA Adds Information on Severe Liver Injury to Leflunomide’s Boxed Warning
The FDA has identified 49 cases of severe liver injury — 14 of which proved fatal — in patients taking the rheumatoid arthritis drug leflunomide, which is marketed as Arava. The agency said in a July 13 safety announcement that it has responded by adding information about severe liver injury to the boxed warning of the product’s package label.
Read more on American Academy of Family Physicians
Posted in Arthritis Treatments |
Tags: Academy Of Family Physicians, Adds, American Academy Of Family Physicians, Arava, Arthritis, Boxed, Fda, information, Injury, Leflunomide, Leflunomide's, Liver, Liver Injury, Rheumatoid Arthritis, Rheumatoid Arthritis Drug, Safety Announcement, Severe, Warning |
No Comments »
Avila’s AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis
Avila’s AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced results of preclinical studies demonstrating that its clinical candidate, AVL-292, potently inhibits B cell receptor signaling, and demonstrates efficacy in a rodent model of rheumatoid arthritis. These new data were presented Saturday, June 26 …
Read more on News-Medical-Net
Chelsea Therapeutics will send RA drug data to FDA
Chelsea Therapeutics International Ltd. said Tuesday it plans to give regulators more data in late July about a potential rheumatoid arthritis drug. The agency had raised concerns earlier this month about liver enzyme levels in some patients taking the drug in trials.
Read more on AP via Yahoo! Finance
Posted in Arthritis Treatments |
Tags: Arthritis, Avila, Avila's, Avl, AVL292, B Cell Receptor, Biotechnology Company, Demonstrates, diseasemodifying, Effects, Efficacy, Fda, International Ltd, Liver Enzyme Levels, Liver Levels, models, Preclinical Studies, prophylactic, Ra, Regulators, Rheumatoid, Rheumatoid Arthritis, Rheumatoid Arthritis Drug, Rodent Model, Saturday June, Therapeutic, Therapeutic Models, Therapeutics Inc, Yahoo Finance |
No Comments »
